Safety and Efficacy Study of Autologous Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis

NCT01363401 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
ALS

Interventions

BIOLOGICAL: HYNR-CS inj
OTHER: Control group

Sponsor

Corestemchemon, Inc.